Canada Places Cancer Warnings On Merck And GSK Drugs

Law360, New York (March 20, 2012, 9:37 PM EDT) -- Canada's health regulator said Monday it has slapped warnings on prescription drugs marketed by Merck & Co Inc. and GlaxoSmithKline PLC that treat enlarged prostates and baldness after finding they could raise the risk of an aggressive form of prostate cancer.

Health Canada added the warnings to Merck's Proscar and Propecia and GlaxoSmithKline's Avodart and Jalyn more than nine months after the U.S. Food and Drug Administration issued similar warnings. Updates to the labels on generic versions of the drugs, called finasteride and dutasteride, will follow,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.